Sequential combination of radio-chemotherapy (5-fluorouracil, cis-platinum and irradiation) in the management of locally advanced head and neck cancers

Neoplasma

Volumn 43, Issue 1, 1996, Pages 37-41

  Suwinski R ^a   Pilecki, B ^a   Skladowski K ^a   Swiatnicka J ^a   Zajusz, A ^a   Przeorek, W ^a   Utracka Hutka, B ^a   Jakus, G ^a   Lange, D ^a   Lange, B ^a   Tarnawski, R ^a   Maciejewski, B ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

head and neck cancer; locoregional tumor control; radio chemotherapy; survival

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; SURVIVAL;

EID: 13344275854     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. BACHOUCHI, M., CVITKOVIC, E., AZLI, N., GASMI, J., CORTES-FUNES, H., BOUSSEN, H., RAHAL, M., KALIFA, C., SCHWAAB, G., ESCHWEGE, F., WIBAULT, P., ARMAND, J.P.: High complete response in advanced nasopharyngeal carcinoma with bleomycin, epinibicin, and cisplatin before radiotherapy. J. Natl. Cancer Inst., 82, 1990, 616-620.
2. BRIZEL, D.M., LEOPOLD, K.A., FISHER, S.R., PANELLA, T.J., FIAE, R.L., BEDROSIAN, C.L., KENAN, P.D., HUANG, A., WOMACK, T., BJUSTROM, T., DODGE, R., PROSNITZ, L.: A phase I/II trial of twice daily irradiation and concurent chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys., 28, 1994, 213-220.
3. CLAVEL, M., MAGED MANSOUR, A.R.: Head and neck cancer: Prognostic factors for response to chemotherapy. Eur. J. Cancer, 21, 1991, 349-356.
4. DIONET, C., ROZAN, R., ACHARD, J.L., VERRELLE, P., DUMESNIL, Y., RUSSIER, M., LEMESLE, PH., THERON, H., LATOUR, M., MONDIE, J.M., LAFAYE, M., BOLLA, M., CHOLLET, PH.: Sequential combination of 5-fluorouracil, cis-platinum and irradiation. I. Advanced head and neck cancers. Radiother. Oncol., 11, 1988, 123-131.
5. DIONET, C., VERRELLE, P.: Curability of mouse L1210 leukemia by combination of 5-Fluorouracil, cis-Diamminedichloroplatinum, and low doses of rays. Cancer Res., 44, 1984, 652-656.
6. FAZEKAS, J.T., SOMMER, C., KRAMER, S.: Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx, or hypopharynx. Int. J. Radiat. Oncol. Biol. Phys., 6, 1980, 533-541.
7. FU, K.K., PHILLIPS, T.L., SILVERBERG, I.Y., JACOBS, C., GOFFINET, D.R., CHUN, C., FRIEDMAN, M.A., KOHLER, M., MCWHIRTER, K., CARTER, S.: Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial. J. Clin. Oncol., 5, 1987, 1410-1418.
8. Head and Neck Contract Program Adjuvant Chemotherapy for Advanced Head and Neck Squamous Carcinoma: Final Report of the Head and Neck Contracts Program. Cancer, 60, 1987, 301-311.
9. HILL, B.T., PRICE, L.A.: The role of adjuvant chemotherapy in the treatment of advanced head and neck cancer. Acta Oncol., 29, 1990, 695-703.
10. KIAN ANG, K., KAANDERS, J.H.A., PETERS, L.J.: Radiotherapy for Head and Neck Cancers: Indications and Techniques. Lea and Febiger 1994.
11. LARAMORE, G.E., SCOTT, C.B., AL-SARRAF, M., HASELOW, R.E., ERVIN, T.J., WHEELER, R., JACOBS, J.R.: Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on Intergroup Study 0034. Int. J. Radiat, Oncol. Biol. Phys., 23, 1992, 705-713.
12. MACIEJEWSKI, B., WITHERS, H.R., TAYLOR, J.M.G., HLINIAK, A.: Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: Tumor dose-response and repopulation. Int. J. Radiat. Oncol. Biol. Phys., 16, 1989, 831-843.
13. OVERGAARD, J., HANSEN, H.S., JORGENSEN, K., HJELM-HANSEN, M.: Primary radiotherapy of larynx and pharynx carcinoma. An analysis of some factors influencing local control and survival. Int. J. Radiat. Oncol. Biol. Phys., 12, 1986, 515-521.
14. SAUNDERS, M.I., DISCHE, S.: Continuous hyperfractionated accelerated radiotherapy (CHART). Sem. Radiat. Oncol., 2, 1992, 41-44.
15. SKOLYSZEWSKI, J., REINFUSS, M.: Evaluation of the efficacy of paliative irradiation with high fractionated doses and planned intervals of patients with advanced cancer of the oral cavity and pharynx. Nowotwory, 4, 1988, 251-260.
16. STEEL, G.G.: Combination of radiotherapy and chemotherapy. In: Basic Clinical Radiobioiogy. Ed.: Steel, G.G., Edward Arnold Publisher 1993, 151-162.
17. TAYLOR IV, S.G., MURTHY, A.K., CADARELLI, D.D., SHOWEL, J.L., KIEL, K., GRIEM, K.L., MITTAL, B.B., KIES, M., HUTCHISON, JR., J. C., HOLINGER, L.D., CAMPANELLA, R., WITT, T.R., HOOVER, S.: Combined simultaneus cisplatin/fluorouracil and split course radiation in head and neck cancer. J. Clin. Oncol., 7, 1989, 846-856.
18. The Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N. Engl. J. Med., 324, 1991, 1685-1690.
19. VALDAGNI, R., AMICHETTI, M.: Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hypothermia to metastatic lymphnodes in Stage IV head and neck patients. Int. J. Radiat. Oncol. Biol. Phys., 28, 1993, 163-169.
20. WENDT, T.G., HARTENSTEIN, R.C., WUSTROW, T.P.U., LISSNER, J.: Cisplatin, fluorouracil with leucovorin calcium enhancement, and synchronous accelerated radiotherapy in the management of locally advanced head and neck cancer: A phase II study. J Clin. Oncol. 7, 1989, 471-476.
21. WITHERS, H.R., TAYLOR, J.M.G., MACIEJEWSKI, B.: The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol., 27, 1988, 131-146.
22. VOKES, E.E.: Continuous intravenous 5-fluorouracil with hydroxyurea and concomitant radiotherapy for advanced head and neck cancer. In: Medical Radiology, Concomitant Continuous Chemotherapy and Radiation. Eds: Rotman, M., Rosenthal, C.J. Berlin, Heidelberg, Springer-Verlag 1991, 161-165.
23. VOKES, E.E., PANJE, W.R., SCHILSKY, R.L., MICK, R., AWAN, A.M., MORAN, W.J., GOLDMAN, M.D., TYBOR, A. G., WEICHSELBAUM, R.R.: Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor prognosis head and neck cancer. A phase I-II study. J. Clin. Oncol., 7, 1989, 761-768.